logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for GSK
ProTradersNews
27 May 15 13:33:04
$GSK: Stock Insights: GlaxoSmithKline PLC (NYSE:GSK): http://t.co/5yW3LTzjc9
vincenzo abruscato
27 May 15 12:59:04
RT @biospace: Glaxo Willing to Give CEO Time to Revive Company http://t.co/Ww8a3nRTYB $GSK #biotech @BestOfBiotech @pharma_global http://t.…
Reggie Noble
27 May 15 12:50:02
$GSK I'm out...Quick 31% profit...
CashRocket
27 May 15 12:34:54
Okay so I am now officially long calls/call spreads/call flys in $PFE $GSK and $SHPG. All bases covered lol
David Oliver
27 May 15 12:16:37
RT @the_sy_guy: I wrote this. Please read it. 3 major trends driving layoffs in #biotech and #pharma: http://t.co/JciD9Po7VL $AZN $GSK $P…
The Motley Fool UK
27 May 15 12:16:08
Why I'm Bullish On #GlaxoSmithKline, Interserve And Carillion http://t.co/Mjng98L0FZ $GSK
Charles Zinnel
27 May 15 12:00:45
$ARIA about to break huge resistance! I'm calling partnership news soon $achn $gild $pfe $jnj $mrk $gsk $aria $ctic $onty #stocks #ASCO15
Charles Zinnel
27 May 15 11:59:52
$ARIA about to break huge resistance! I'm calling partnership news soon!! $achn $gild $pfe $jnj $mrk $gsk $jpm $aria $ctic $onty #stocks
Charles Zinnel
27 May 15 11:58:20
$NBY SURGING nearly 10%!!! $achn $gild $pfe $jnj $mrk $gsk $jpm $aria $ctic $onty #stocks #monty #cnbc
BioPharma Dive
27 May 15 11:57:59
3 major trends driving layoffs in #biotech and #pharma: http://t.co/cWOh4LRYL8 $AZN $GSK $PFE $AMGN $SHPG $AGN $ACT http://t.co/ZTQaOezsHa
Kristina Duering
27 May 15 11:32:49
RT @bret_jensen: Big Pharma Companies Are Betting On Regenerative Medicine, Should You? $GSK $CELG $PFE $JNJ $TEVA $CAPR $ENDV http:/…
Stock Dawgzz
27 May 15 10:56:21
We released a secret penny stock pick to our platinum members and it's moving up fast! Get special access: http://t.co/qCRGCZC0gC $LFAP $GSK
Penny Stockington
27 May 15 10:54:55
Our Penny Stock Alerts Gained Over 3400% For Subscribers In 7 Months! See Our New Picks: http://t.co/nLJyVU6RRw $LFAP $GSK $ROX
StockenheimerSchmidt
27 May 15 10:53:23
3400% Gains On Penny Stock Picks In 7 Months & A Secret New Pick Is Out Today! See It Early: http://t.co/RdlD84A2Ko $LFAP $GSK $ROX
Stock Rocket
27 May 15 10:51:52
Our Stock Alerts Gained Over 1300% In Less Than 3 Months! See Our New Picks: http://t.co/keLIhbtrUQ $LFAP $GSK $ROX
Stockaholics
27 May 15 10:51:03
Our Penny Stock Pick On $THCZ Is Up 570.77% For Platinum Members! Big Update: http://t.co/dXhKtfZvCq $LFAP $GSK $ROX
D Robertson
27 May 15 09:42:17
@PC_Trades the only thing remotely interesting was $GSK and it has 4yr declining revenue so I passed
mazlat
27 May 15 08:43:35
Commented on: "Our 2 Healthcare Picks For April" http://t.co/T2ZRQmIje3 $SYN $GSK
Sy Mukherjee
27 May 15 08:03:52
I wrote this. Please read it. 3 major trends driving layoffs in #biotech and #pharma: http://t.co/JciD9Po7VL $AZN $GSK $PFE $AMGN $SHPG
BioPharma Dive
27 May 15 07:37:35
3 major trends driving layoffs in #biotech and #pharma: http://t.co/cWOh4LRYL8 $AZN $GSK $PFE $AMGN $SHPG $AGN $ACT $SLXP
Kendall Trade
27 May 15 07:33:22
Alert !!! $PBMD new contract with $GSK....20% up in seconds...
Kendall Trade
27 May 15 07:29:18
$PBMD and $GSK new contract..!!!!
Real Brian Watt
27 May 15 07:16:36
@ChiTownBA (cont) just idiotic to go long $GSK when i was calling for like bad week in the market lol...horrible trade lol
Rachel Smith
27 May 15 07:02:06
$GSK - Did BioMarin Bet on the Wrong Experimental DMD Drug? http://t.co/9AxbxhdXpJ
NASDAQ
27 May 15 07:02:04
$GSK - Did BioMarin Bet on the Wrong Experimental DMD Drug? http://t.co/Cu8bvcoD9X
StockNews
27 May 15 07:02:00
$GSK - Did BioMarin Bet on the Wrong Experimental DMD Drug? http://t.co/DwKhKMeBdC
Market Int Center
27 May 15 05:40:29
GlaxoSmithKline PLC $GSK Trading Near $43.21 Support Level ( http://t.co/1zAGcoe1Ny )
Kevin Olson
27 May 15 05:23:59
@OpenOutcrier Didn't $GSK show bullish flow last week? Hmmm...
Privilege Physicians
27 May 15 04:17:30
RT @the_sy_guy: .@ProPublica opens up the #Advair vault, raises safety and #marketing #ethics questions: http://t.co/cBOYGcI8gT $GSK
The Duke
27 May 15 04:11:04
RT @Ablate_Cancer: GSK, Pfizer among Big Pharmas bailing on Chinese sales as provinces squeeze prices - FiercePharma: $RHHBY $pfe $gsk http…
Stock Dawgzz
27 May 15 03:46:11
We Have A Huge New Penny Stock Pick Coming Today! Get Exclusive Access: http://t.co/qCRGCZkoS2 $LFAP $GSK $ROX
Penny Stockington
27 May 15 03:41:25
Our Penny Stock Alerts Gained Over 3400% For Subscribers In 7 Months! See Our New Picks: http://t.co/nLJyVU6RRw $LFAP $GSK $ROX
Stock Rocket
27 May 15 03:36:01
Our Stock Alerts Gained Over 1300% In Less Than 3 Months! See Our New Picks: http://t.co/keLIhbbQwg $LFAP $GSK $ROX
Stockaholics
27 May 15 03:34:27
Our Penny Stock Pick On $THCZ Is Up 570.77% For Platinum Members! Big Update: http://t.co/dXhKtfHUdQ $LFAP $GSK $ROX
Okee Williams
27 May 15 03:19:51
RT @biospace: BREAKING: @pfizer Will Make $120B Bid for Glaxo in Q2: Poll http://t.co/mlgDkXf8pQ $GSK @WSJ @TSTbiotech @business http://t.…
StockenheimerSchmidt
27 May 15 03:19:01
3400% Gains On Penny Stock Picks In 7 Months & A New One Is Coming Today! See It Early: http://t.co/RdlD84irlO $LFAP $GSK $ROX 3400
Sleek Money
26 May 15 23:37:35
GlaxoSmithKline plc Receives Underweight Rating from JPMorgan Chase & Co. $GSK http://t.co/JzL3i3wWwy
Ticker Report
26 May 15 23:27:00
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. $GSK http://t.co/b7kkggR45m
WKRB News
26 May 15 23:22:23
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. $GSK http://t.co/r5aKATuL2K
US Consumer News
26 May 15 23:09:31
GlaxoSmithKline plc's underweight rating reiterated at JPMorgan Chase & Co.. GBX 1,320 PT. http://t.co/C3UUsrktTK $GSK #GSK
Analyst Ratings
26 May 15 23:05:07
GlaxoSmithKline plc's underweight rating reiterated at JPMorgan Chase & Co.. GBX 1,320 PT. http://t.co/sVePosP3TL $GSK #GSK
TalkMarkets
26 May 15 21:39:03
Big #Pharma Companies Are Betting On Regenerative Medicine, Should You? $GSK $CELG $PFE $JNJ $MBLTY $TEVA $CAPR $ENDV http://t.co/VDxQbTji3b
Jason Olive
26 May 15 20:47:23
RT @SeekingAlpha: Why Dividend Investors Should Love These 5% Yielding European Stocks http://t.co/osEjuhAXSH $BP $RDS.B $GSK
Tomeka Haywood
26 May 15 20:43:17
RT @SeekingAlpha: Why Dividend Investors Should Love These 5% Yielding European Stocks http://t.co/osEjuhAXSH $BP $RDS.B $GSK
Healthcare Stocks
26 May 15 20:42:33
Why Dividend Investors Should Love These 5% Yielding European Stocks http://t.co/mfIpbLnss3 $BP $RDS.B $GSK
Income Investing SA
26 May 15 20:42:33
Why Dividend Investors Should Love These 5% Yielding European Stocks http://t.co/FJ2RYWbj4R $BP $RDS.B $GSK
Dividend Investing
26 May 15 20:42:32
Why Dividend Investors Should Love These 5% Yielding European Stocks http://t.co/6QQf1q2kBq $BP $RDS.B $GSK
Seeking Alpha
26 May 15 20:42:32
Why Dividend Investors Should Love These 5% Yielding European Stocks http://t.co/osEjuhAXSH $BP $RDS.B $GSK
$PVCT
26 May 15 19:48:14
GSK, Pfizer among Big Pharmas bailing on Chinese sales as provinces squeeze prices - FiercePharma: $RHHBY $pfe $gsk http://t.co/FdJK5HAf0f
Penny Stockington
26 May 15 17:27:54
Our Penny Stock Alerts Gained Over 3400% For Subscribers In 7 Months! See Our New Picks: http://t.co/nLJyVU6RRw $LFAP $GSK $ROX
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN